— Know what they know.
Not Investment Advice

CBUS NASDAQ

Cibus, Inc.
1W: +12.5% 1M: +9.6% 3M: +21.3% YTD: -9.0% 1Y: +27.6% 3Y: -90.7% 5Y: -99.0%
$1.71
+0.08 (+4.91%)
 
Weekly Expected Move ±8.3%
$1 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $130.5M mcap · 47M float · 0.529% daily turnover · Short 65% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$130.5M
52W Range1.09-4.191
Volume247,441
Avg Volume247,780
Beta1.59
Dividend—
Analyst Ratings
3 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOCraig Wichner
Employees118
SectorHealthcare
IndustryBiotechnology
IPO Date2017-07-20
Websitecibus.com
6455 Nancy Ridge Drive
San Diego, CA 92121
US
858 450 0008
About Cibus, Inc.

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Recent Insider Trades

NameTypeSharesPriceDate
Wichner Craig A-Award 894,309 — 2026-06-08
Wichner Craig A-Award 1,047,620 $1.23 2026-06-08
Urban Thomas A-Award 64,748 — 2026-06-02
Box Kimberly Ann A-Award 77,586 $1.39 2026-06-02
Wichner Craig A-Award 77,586 $1.39 2026-06-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms